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ABSTRACT
Introduction: Dizziness is a common symptom in
general practice with a high prevalence among older
adults. The most common cause of dizziness in
general practice is peripheral vestibular disease.
Vestibular rehabilitation (VR) is a safe and effective
treatment for peripheral vestibular disease that entails
specific exercises to maximise the central nervous
system compensation for the effects of vestibular
pathology. An internet-based VR intervention has
recently been shown to be safe and effective. Online
interventions are low cost and easily accessible, but
prone to attrition and non-adherence. A combination of
online and face-to-face therapy, known as blended
care, may balance these advantages and
disadvantages.
Methods and analysis: A single-blind, three-arm,
randomised controlled trial among patients aged
50 years and over presenting with dizziness of
vestibular origin in general practice will be performed.
In this study, we will compare the clinical and cost-
effectiveness of stand-alone internet-based VR and
internet-based VR with physiotherapeutic support
(‘blended care’) with usual care during 6 months of
follow-up. We will use a translated Dutch version of a
British online VR intervention. Randomisation will be
stratified by dizziness severity. The primary outcome
measure is the Vertigo Symptoms Scale—Short Form.
Intention-to-treat analysis will be performed, adjusting
for confounders. The economic evaluation will be
conducted from a societal perspective. We will perform
an additional analysis on the data to identify predictors
of successful treatment in the same population to
develop a clinical decision rule for general
practitioners.
Ethics and dissemination: The ethical committee of
the VU University Medical Center approved ethics and
dissemination of the study protocol. The insights and
results of this study will be widely disseminated
through international peer-reviewed journals and
conference presentations.
Trial registration number: Pre-results, NTR5712.
INTRODUCTION
Dizziness is a common symptom in general
practice.1 Among adults, the life-time preva-
lence of dizziness has been reported to be
20–30%.2–4 The prevalence of dizziness
increases with age; in adults over 85 years
old, the prevalence exceeds 50%.5 Dizziness
is associated with a lower quality of life, occu-
pational consequences and substantial inter-
ference with daily activities.6 It is a major risk
factor for falling, which can be especially
harmful for older adults who are prone to
fractures.7 Owing to a decrease in work prod-
uctivity and the high costs of medical care,
Strength and limitations of this study
▪ This is a protocol for the first randomised con-
trolled trial in general practice that investigates
the effectiveness of the combination of online
vestibular rehabilitation (VR) and face-to-face
therapy (blended care) as a form of treatment for
patients with dizziness of vestibular origin.
▪ By using a three-arm design, we will investigate
the effectiveness and cost-effectiveness of
stand-alone internet-based VR and blended care
compared to usual care during 6 months of
follow-up.
▪ We will attempt to develop a clinical decision
rule for predictors of successful treatment to
ensure personalised treatment. This will allow
general practitioners to discriminate between
patients who should receive stand-alone internet-
based VR and those who are more likely to
benefit from a blended care approach.
▪ Our internet-based intervention was designed for
patients aged 50 years and over with access to
the internet. Owing to these requirements, the
treatment might not be accessible to all adult
patients with dizziness of vestibular origin.
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dizziness also constitutes a substantial economic
burden.4
The most common cause of dizziness in general prac-
tice is peripheral vestibular disease (33–38%), which
includes benign paroxysmal positional vertigo (BPPV),
vestibular neuronitis and Ménière’s disease (MD). Other
causes of dizziness are cardiovascular diseases (7–18%),
neurological disorders (10–15%) and psychiatric disor-
ders (1–17%).8–10 In the Netherlands, as well as in the
UK and the USA, >90% of all patients with dizziness are
treated by their general practitioner (GP) without any
involvement of a specialist,9–11 mainly by reassurance,
advice and symptomatic drug prescriptions.11 However,
none of the commonly prescribed drugs for vertigo have
a well-established curative or preventive effect.12
According to a recent Cochrane review—based on 39
randomised controlled trials (RCTs) involving 2441 par-
ticipants—there is moderate-to-strong evidence that ves-
tibular rehabilitation (VR) is a safe, effective treatment
for peripheral vestibular disease.13 VR entails that the
patient carries out graded exercises for 10–20 min daily
for 6–12 weeks. These exercises include speciﬁc eye,
head and body movements that stimulate the vestibular
system and promote neurological adaptation to the
altered input from the damaged labyrinth.14 15
Performing these exercises may also help patients to
overcome fear and avoidance of activities that provoke
dizziness, and to regain skill and conﬁdence in
balance.14 16 Importantly, when examining the 39 RCTs
mentioned above,13 most RCTs were performed among
a selected population (eg, participants with canal
paresis, otolith disorder or acoustic neuroma resection)
and were conducted in a secondary/tertiary care setting.
Only 2 of the 39 RCTs included a population representa-
tive of patients seen in primary care, these showed that
nurse-delivered VR and booklet-based VR effectively
reduce dizziness.14 17
Despite the evidence for the effectiveness of VR, a pre-
vious survey suggests that <3% of eligible primary care
patients with dizziness ever receive VR.17 This may be
due to a lack of availability or access to VR or a lack of
knowledge about VR by the GP.11 To date, access to VR
usually involves a costly referral process to secondary
care.18 Also, ﬁnding suitable therapists can be difﬁcult.14
Prior to this proposal, we performed a survey among a
sample of 1169 Dutch GPs to investigate the current use
of VR in general practice.19 Of the 426 responding GPs,
93% reported that they never used VR—by themselves or
by referral—for the treatment of patients with dizziness.
Not knowing how to perform the technique was the most
mentioned reason by GPs not to use VR (92.4%). ‘Takes
too much time to execute’ (7.2%), ‘doubts about the
effectiveness’ (6.3%) and ‘not recommended by national
guidelines’ (4.5%) were other reasons mentioned by GPs
for not using VR. Consequently, it is not only important
to generate additional evidence for the effectiveness of
VR in general practice, but also to consider alternative
models of treatment delivery to support the GP.
In the past, VR has been successfully delivered via a
booklet-based self-management programme. Booklet-
based VR has been tested in two large primary care
trials14 17 and a voluntary population of members of the
Meniere’s Society.20 All trials showed that application of
VR resulted in a signiﬁcant reduction of dizziness symp-
toms without any serious adverse events.14 17 20 The
internet could prove to be an alternative method to
reach patients with dizziness in an inexpensive, easily
accessible way. Booklet-based treatments are perfectly
suited to be transformed into internet-based interven-
tions. An online intervention can be tailored to the
patients’ individual needs, featured audio–visual content
and provided various means of motivational support
(eg, discussion boards or personalised text messages).21
Internet use by older adults is growing rapidly.
According to Statistics Netherlands (CBS), 80% of
adults aged 65–75 years reported internet use in 2013,
which is more than twice as much as in 2005.22 A recent
review by Aalbers et al23 showed that internet interven-
tions targeting lifestyle change in adults aged above
50 years can be effective. The authors concluded that
internet-mediated interventions hold great potential in
implementing effective lifestyle programmes and are
capable of reaching large populations of older persons
at low costs.23 With these advantages in mind, an online
VR intervention based on the VR booklet was developed
in the UK.18 The internet-based VR intervention has
recently been compared to usual care in an RCT
(Geraghty et al personal communication). The trial was
conducted in a general practice population and
included 296 patients. Patients in the online VR inter-
vention group experienced signiﬁcantly less dizziness
and dizziness-related disability at 6 months, compared to
those in the usual care group. We will translate the
British online VR intervention into Dutch. No altera-
tions in the content of the translated programme will be
made.
In addition to this, we will also investigate a different
form of delivery in which the use of the online interven-
tion is supported by a healthcare professional. Despite
the advantages, unguided internet interventions can be
associated with substantial attrition and non-adherence.
A combination of online and face-to-face therapy
(‘blended care’) may reduce attrition and non-
adherence, offering patients the best of both worlds.24–26
In one of the booklet-based VR trials,14 a subset of
patients received additional telephone support by a
trained vestibular therapist while performing the booklet
self-managed programme. By focusing on addressing
patient concerns, reassuring, encouraging adherence
and ensuring proper use of the booklet, these patients
demonstrated higher adherence to the treatment and a
signiﬁcant reduction in anxiety and depression.
Face-to-face contact is likely to be even more effective
than telephone support. In the Netherlands, phy-
siotherapists with experience in vestibular therapy often
make house calls, and they are used to encourage and
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reassure their patients when performing physical exer-
cises. As such, they are perfectly suited to be the ‘face’ of
an online VR intervention.
The principal aim of this research project is to investi-
gate the effectiveness and cost-effectiveness of
stand-alone internet-based VR and internet-based VR
with physiotherapeutic support (blended care) for
patients with dizziness aged 50 years and over in general
practice in comparison with usual primary care. The
online intervention that will be applied has been proved
to be safe and effective for patients aged 50 years and
over (Geraghty et al personal communication). By asses-
sing the beneﬁts of blended care, we may be able to
improve the treatment of older patients with dizziness.
Furthermore, it will offer GPs a new—immediate, easily
accessible and inexpensive—clinical tool for treating diz-
ziness in general practice. Additionally, we aim to
develop a prediction rule to help GPs to assess which
patient groups are best suited for each type of
treatment.
METHODS AND ANALYSIS
Study design
We will perform a single-blind, three-arm, RCT among
patients aged 50 years and older presenting with dizzi-
ness in general practice. We will compare the clinical
and cost-effectiveness of stand-alone internet-based VR
and internet-based VR with physiotherapeutic support
(‘blended care’) with usual care. The intervention
period will last 6 weeks and patients will be followed up
at 3 and 6 months. The primary outcome measure will
be dizziness symptoms at 6 months as measured by the
Vertigo Symptom Scale-Short Form (VSS-SF). Figure 1
represents a ﬂow chart of the study with an overview of
the group classiﬁcation and randomisation. By using the
LifeGuide software, we will automatically (and non-
intrusively) collect data on all aspects of intervention
use, including which sections and pages are viewed, how
often and for how long. In addition to this, we will
perform semistructured interviews with 10–15 partici-
pants from trial arm 1 (stand-alone internet-based VR)
and 10–15 participants from trial arm 2 (internet-based
VR with physiotherapeutic support) to assess their
experiences with the online intervention.
Recruitment of study participants
The large majority of patients will be recruited from the
Academic Network of General Practices of the VU
University Medical Center (ANH-VUmc). The ANH-
VUmc includes a total of 50 active GPs. The network
should be a sufﬁcient source to attain our inclusion
number. Other general practices in the Netherlands
(primarily in and around Amsterdam) may be
approached if inclusion numbers from the ANH-VUmc
prove to be insufﬁcient. Eligible patients will be identi-
ﬁed by means of a validated search strategy27 that selects
from the electronic medical records those patients
within the set age range who visited their GP because of
dizziness in the past 2 years. The GP will screen the
selected lists of patients for potential exclusion criteria
or other pertinent reasons for not inviting them, such as
a terminal disease or a severe psychiatric disorder. The
identiﬁed and screened potential participants will be
sent a package by their GP containing a letter, a bro-
chure with information about the trial and a contact
form. If a patient is willing to participate, he/she can
contact the research assistant by phone, email or by
returning the addressed contact form. On making
contact, the research assistant will provide additional
information if necessary and check the eligibility cri-
teria. These criteria are a good command of the Dutch
language, access to the internet and an email account,
persisting dizziness at time of inclusion that has been
present for at least 1 month, and that is exacerbated by
performing head movements. If the participant is eli-
gible, the research assistant will make an appointment
for a visit at the participant’s home. The research assist-
ant will bring an informed consent form with an
addressed return envelope. The participant will be able
to ask questions about the trial and the informed
consent form during this house visit. After the house
visit, the participant will be given 1–2 weeks of time to
consider if he/she wants to participate in the trial.
During that time period, the research assistant will be
available to answer any questions over the phone that
might arise. To participate, the individual is required to
sign the informed consent form and return it to the
research team by using the addressed return envelope.
After this signed informed consent form has been
received by the research team, an email will be sent to
the participant with a link to the intervention website.
Sample size and power calculation
The sample size calculation for our trial is based on the
comparison between participants allocated to trial arm 1
(stand-alone internet-based VR) and those allocated to
trial arm 3 (usual care). In Yardley et al’s14 recent VR trial
with VSS-SF as a primary outcome measure, booklet-based
VR alone, compared with routine care, showed an effect
size (Cohen’s d) of 0.45, favouring booklet-based VR.
Assuming that stand-alone internet-based VR will produce
the same effect size as booklet-based VR alone, we will
need 80 patients per group to test a two-tailed hypothesis
with α=0.05 and β=0.20. As attrition from internet-based
interventions can be substantial,25 we will recruit a
minimum of 100 participants per group (300 total
sample) to allow for up to 20% attrition (80×100/80=100).
Eligibility criteria
Eligible patients are required to:
▸ be 50 years or older,
▸ possess a good command of the Dutch language,
▸ have access to internet and an email account,
▸ have consulted a GP with dizziness symptoms in the
last 2 years,
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▸ still experience dizziness at the time of inclusion,
which has to have been present for at least a month
and
▸ experience dizziness exacerbated by head move-
ments; otherwise, the dizziness is unlikely to have a
vestibular origin.14
The cut-off point for duration at 1 month was chosen
because of acute BPPV; the Epley manoeuvre is deemed
superior to VR. After 1 month, both treatments are con-
sidered equally effective.28 Reasons for exclusion are: an
identiﬁable non-vestibular cause of dizziness in the
electronic record of the patient; medical contraindica-
tions for making the required head movements (eg,
severe cervical arthrosis); serious comorbid conditions
that preclude participation in an exercise programme or
current enrolment in another—interfering—study.
Randomisation and blinding
All patients are required to complete baseline measures
online. The online software programme will randomly
assign participants to one of the three arms. During the
automated randomisation, patients will be stratiﬁed by
Figure 1 Flow-chart study. PT, physiotherapy; VR, vestibular rehabilitation.
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dizziness severity according to their score on the VSS-SF.
Participants with a VSS-SF score of <12 points will be
classiﬁed as low severity patients, whereas participants
with 12 or more points will be classiﬁed as high severity
patients. Patients are automatically informed about their
allocated group. When patients are allocated to trial arm
2 (blended care), an email will be sent to the principal
investigator. The principal investigator will select and
contact one of the trained physiotherapists, depending
on the location of the patient. The physiotherapist will
contact the patient within 24 hours to plan the ﬁrst
therapeutic session. Since VR is a behavioural interven-
tion, it is not possible for patients to be blinded to
allocation. At 3 and 6 months, they will receive an
email—and, if necessary, a reminder—to complete
follow-up measures online. If participants still fail to
respond, an independent research assistant will call
them to encourage them to ﬁll out the questionnaires
online. The research assistant analysing the question-
naire data will be blind to treatment allocation.
Intervention
Internet-based VR (trial arm 1)
VR entails speciﬁc exercises with the aim of maximising
central nervous system compensation for vestibular
pathology. Recently, speciﬁc components have been
deﬁned, namely compensation (using motion to
habituate or reduce responsiveness to repetitive stimuli
and to rebalance tonic activity within the vestibular
nuclei), adaptation (using repetitive and provocative
movements of the head and/or eyes to reduce error
and restore vestibule-ocular reﬂex gain), substitution
(promoting the use of individual or combinations of
sensory inputs) and motor learning principles (chan-
ging movement behaviour). Additionally, deliberately
provoking dizziness in a controlled context functions as
a form of exposure-based behaviour therapy.15 18 A VR
booklet was developed by following principles of behav-
iour change, derived from cognitive–behaviour therapy
and self-regulation theory.14 Self-efﬁcacy is stimulated
in the intervention by graded goal setting. This VR
booklet was validated in three large trials.14 17 20 The
content of the booklet has been the basis for a recently
developed stand-alone internet-based VR intervention.
This intervention was developed by Dr Lucy Yardley,18
member of our research group and coauthor of this
manuscript. A prototype version of the intervention was
tested among 18 adults in the UK.29 Participants were
positive regarding how easy to navigate, visually appeal-
ing and informative they found the intervention.
Think-aloud sessions provided valuable data for inform-
ing small amendments to further enhance acceptability
of the intervention for target users.29 The recently con-
ducted large trial by Geraghty et al (n=296) (Geraghty
et al personal communication) has shown that the
British version of internet-based VR improves dizziness
and reduces dizziness-based disability in older primary
care patients. Patients in trial arm 1 will get access to a
careful Dutch translation of this stand-alone VR
intervention.
The intervention period will last 6 weeks for every
patient. In the ﬁrst session, information about dizziness
and a rationale for the VR exercises will be provided.
These exercises represent the core of the intervention.
The weekly ‘timed exercise scoring test’ (TEST) will also
be explained in the ﬁrst session. VR exercises will be per-
sonalised for the patient and take into account his/her
symptoms and balance capabilities. The online TEST is
used to tailor the set of exercises. All of the exercises
will have written instructions with video demonstrations,
each performed by a male and a female model. In the
ﬁrst session, all six exercises (see box 1) are performed
sitting down, afterwards the patients are asked to score
how dizzy each respective exercise made them feel. The
intervention uses these scores to automatically produce
an exercise prescription for the coming week, custom
built to the patient’s dizziness symptoms. When perform-
ing the exercises while sitting no longer causes dizziness
symptoms, the patient will be asked to perform the exer-
cises standing up. By using this approach, patients will
gradually increase the intensity of their exercises.
Patients are asked to perform these exercises two times
per day for 10 min. Patients will complete a different
online session every week in the 6-week intervention
period.
The intervention incorporates information and advice
on behavioural coping strategies. Previous research
showed that symptom control strategies led to signiﬁ-
cant subjective health improvement and reduction of
dizziness-related impairment.20 Progressive muscle
Box 1 Exercises
1. Shake: Turn your head from right to left and back again 10
times in 10 s. Twist your head round as far as it will go comfort-
ably when you do this, and look in the direction your head is
pointing. Wait 10 s after you have performed 10 complete turns,
and then do 10 more.
2. Nod: Nod your head up and down and back again 10 times in
10 s. Tip your head as far as it will go comfortably when you do
this, and look in the direction your head is pointing. Wait 10 s after
you have performed 10 complete turns, and then do 10 more.
3. Shake, eyes closed: Carry out the shake exercise with your eyes
closed. Wait 10 s after you have performed 10 complete turns,
and then do 10 more.
4. Nod, eyes closed: Carry out the nod exercise with your eyes
closed. Wait 10 s after you have performed 10 complete turns,
and then do 10 more.
5. Shake/stare: Hold your finger pointing upwards in front of you
and carry out the shake exercise while staring at your finger. Do
not let your eyes move from your finger. Wait 10 s after you have
performed 10 complete turns, and then do 10 more.
6. Nod/stare: Hold your finger pointing sideward in front of you
and carry out the nod exercise while staring at your finger. Do not
let your eyes move from your finger. Wait 10 s after you have per-
formed 10 complete turns, and then do 10 more.
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relaxation and breathing techniques can decrease
dizziness-associated psychophysiological arousal, whereas
cognitive restructuring (challenging negative dizziness-
related thoughts) and problem solving may lessen
dizziness-provoking anxiety.30 In addition, the internet
intervention includes particular features to increase
engagement. Scientiﬁc studies supporting the effective-
ness of VR are summarised in plain language to
increase patients’ expectations regarding the interven-
tion content. Email messages will be used to remind
patients to log in to the intervention each week. Since
our intervention is aimed at older adults, the look and
design of the internet-based VR programme is simple
with large font sizes and use of bullet points instead of
paragraphs wherever possible. Importantly, internet-
based VR will be offered to patients in addition to their
usual GP care (ie, the intervention does not replace
usual GP care).
Internet-based VR and physical therapy
(trial arm 2—blended care)
Patients in trial arm 2 (n=100) will receive the same
intervention as the patients in trial arm 1 (n=100). This
internet-based VR intervention is described in detail in
the previous paragraph. In addition to the internet-
based VR intervention, patients in trial arm 2 will
receive two sessions by a trained physiotherapist.
Although the advantages of a stand-alone internet-
based intervention are numerous (eg, easily accessible,
inexpensive, enormous reach and automated tailoring),
unguided internet interventions can be jeopardised by
substantial attrition (ie, a patient leaves the treatment
before the treatment goals are achieved) and non-
adherence (ie, a patient remains enrolled, but fails to
attend the scheduled treatment). Previous research on
depression showed that combining online sessions and
regular face-to-face psychotherapy can increase adher-
ence and effectiveness.24–26 Patients allocated to trial
arm 2 will receive such blended care. The physiothera-
peutic sessions will occur in week 1 and 3 of the
6-week intervention period and last for 45 min each.
During these sessions, the physiotherapist will (1)
provide information about the background of dizziness
and VR; (2) elicit and address doubts and concerns
about dizziness and VR; (3) teach the patient how to
use the online intervention; (4) describe and take the
patient through a set of VR exercises; (5) advise on
how to anticipate and cope with obstacles to adherence
and (6) provide support and encourage adherence.
The ﬁrst session will focus on making the patient feel
comfortable with the VR exercises. The second session
will focus more on adherence to the treatment and will
therefore be planned in the third week. Performing VR
exercises can slightly increase the dizziness at ﬁrst.
During the second session, the physiotherapist will
reassure the patient of the temporary nature of this
exacerbation and encourage him/her to keep perform-
ing the exercises. The sessions will take place at the
home of the participant. A physiotherapist, specialised
in VR, will oversee that all participating physiotherapists
adhere to the treatment protocol. We will conduct a
process evaluation with the physiotherapists after the
trial is completed.
Usual care (trial arm 3)
All included patients of trial arm 3 (n=100) will receive
usual care by their GPs. After randomisation, they will
be redirected to a web page within the intervention that
provides more information about the content of their
trial arm. They will not receive access to online VR at
this time, but will get access after the trial is completed.
It is emphasised that their cooperation in the trial is
vital for the success of the trial. They are asked to log in
to ﬁll out the follow-up questionnaires after 3 months
and 6 months. Participating GPs will receive a written
instruction, asking them to diagnose causes of dizziness
according to the Dutch guideline on dizziness31 and to
treat identiﬁed disorders according to the guidelines of
the Dutch College of GPs.31
Adverse events
VR rarely causes adverse events. Previous trials with the
validated VR booklet did not report any serious adverse
events related to dizziness or the intervention.14 17 20 A
small proportion of patients reported minor, transient
side effects like neck pain, feelings of nausea and an
increase in dizziness. Recently, the results of the trial by
Yardley et al (n=296) have illustrated the safety of
internet-based VR (Geraghty et al personal communica-
tion). Eighteen hospitalisations were identiﬁed in a GP
notes review undertaken at the end of the trial, 8 in the
usual care arm and 10 in the intervention arm. None of
these hospitalisations were related to dizziness. No dizzi-
ness/intervention-related serious adverse reactions were
reported. Our version of the intervention will be a close
Dutch translation of the British online VR intervention.
Patients will be informed that minor side effects like a
temporary increase of neck pain, nausea or dizziness
may occur. They will be advised that these sensations are
likely to disappear within 2 weeks by performing the
exercises more slowly. All adverse events that occur to a
participant during this study, whether or not considered
related to VR, will be recorded. The Medical Ethical
Committee of the VU Medical Center will be notiﬁed
within 15 days in the case of the occurrence of a serious
adverse event during the study. We will inform the parti-
cipants and the Medical Ethical Committee if anything
occurs, on the basis of which it appears that the disad-
vantages of participation may be signiﬁcantly greater
than that was foreseen in the research proposal. The
study will then be suspended pending further review by
the Medical Ethical Committee. Serious medical compli-
cations as a result of our VR intervention are very
unlikely. Previous trials have generated a considerable
body of evidence for the safety of VR13 14 17 20 (Geraghty
et al personal communication).
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Data collection and storage
The Dutch intervention platform will be created using
the LifeGuide software (https://www.lifeguideonline.
org). LifeGuide is a set of open source software tools,
which allows intervention designers to create interactive
web-based interventions. The University of Southampton
developed the LifeGuide software in 2008. Since then,
numerous successful internet-based intervention trials
using LifeGuide have been performed and published in
high-impact scientiﬁc journals. These trials include
public health interventions (eg, smoking cessation)32
and illness management interventions.33 34 The
LifeGuide software not only allows the user to create the
intervention but also contains a data management
system. LifeGuide collects output data on participant use
and outcomes, stores it securely and provides facilities
for collating and providing anonymised data.21 Patients
will ﬁll out a questionnaire at baseline, 3 months
follow-up and 6 months follow-up. By using the
LifeGuide software, we will also automatically (and non-
intrusively) collect data on all aspects of intervention
use, including which sections and pages are viewed, how
often and for how long. We will use participant identiﬁ-
cation numbers and the principal investigator will safe-
guard the key to the code of the participant
identiﬁcation number. Only the principal investigator
and the research assistants will have access to the source
data. Data will be stored on the LifeGuide servers in the
UK. These servers are protected by the ﬁrewall of the
University of Southampton, in accordance with the data
protection policy of this institution. Researchers from
the VU Medical Center and the University of
Southampton signed a data processing agreement. Data
will be kept for as long as the study takes, and at least
15 years after completion. Handling of the data complies
with the Dutch Personal Data Protection Act.
Measures
A list of all measures and the moment at which they are
collected is displayed in table 1.
Demographic characteristics
Patients are asked to complete seven demographic ques-
tions regarding age, gender, living situation, comorbid-
ities and level of education and ﬁve questions about the
nature of their dizziness symptoms at baseline. These
questions are designed by the research team and are
based on previously used baseline measures.14 17 20
Primary outcomes
The primary outcome measure will be dizziness symp-
toms at 6 months. The VSS-SF,13 35 a short-form version
of the VSS,36 will be used to measure this. It is based on
the frequency of 15 dizziness-related symptoms during
the past month on a scale from 0 (no symptoms) to 4
(symptoms most days). Improvement can reﬂect either
fewer or less frequent symptoms. The VSS-SF measures a
broad concept of dizziness for which construct validity
has been demonstrated. It has been used effectively in
many previous VR trials14 17 20 (Geraghty et al personal
communication), and demonstrated excellent discrim-
inative ability (area under the curve (AUC) 0.87), high
internal consistency (Cronbach’s α 0.90) and high test–
retest reliability (intraclass correlation coefﬁcient (ICC)
0.88).37
Health economic outcome measures
Costs will be measured from a societal perspective
according to the Dutch guidelines for economic evalua-
tions38 using internet questionnaires based on the iMTA
Medical Consumption Questionnaire (iMCQ)39 and the
iMTA Productivity Cost Questionnaire (iPCQ)40 at base-
line, and after 3 and 6 months of follow-up. Healthcare
costs include costs of primary and secondary care, com-
plementary care and home care. Productivity costs
include absenteeism from paid and unpaid work, and
presenteeism (being present at work but not being able
to work to one’s full potential due to health symptoms).
The friction cost approach will be used to estimate lost
productivity costs. For the valuation of healthcare utilisa-
tion, standard prices published in the Dutch costing
guidelines will be used. Medication use will be valued
using prices of the Royal Dutch Society for Pharmacy.41
Quality of life will be evaluated using the 5-level
EuroQol 5-dimension questionnaire (EQ-5D-5L)42 at
baseline, and after 3 and 6 months of follow-up. The
EQ-5D-5L is a self-report questionnaire consisting of ﬁve
dimensions on which respondents indicate their own
health state. The Dutch EQ-5D tariff will be used to cal-
culate Quality-Adjusted Life-Years (QALYs).
Secondary outcomes
Dizziness-related impairment
We will assess dizziness-related impairment by using the
Dizziness Handicap Inventory (DHI) at baseline, and
Table 1 Outcome measures and times of collection
within the trial
Measure Baseline
3-month
follow-up
6-month
follow-up
Demographics X
VSS-SF X X X
iMCQ X X X
iPCQ X X X
EQ-5D-5L X X X
DHI X X X
SI X X
PHQ X X X
PETS X X
DHI, Dizziness Handicap Inventory; EQ-5D-5L, 5-level EuroQol
5-dimension questionnaire; iMCQ, iMTA Medical Consumption
Questionnaire; iPCQ, iMTA Productivity Cost Questionnaire;
PETS, Problematic Experiences of Therapy Scale; PHQ,
PRIME-MD Patient Health Questionnaire; SI, Subjective
Improvement in Dizziness Symptoms; VSS-SF, Vertigo Symptoms
Scale—Short Form.
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after 3 and 6 months of follow-up. The DHI has 25 items
with three answer categories (‘yes’, ‘sometimes’ or ‘no’),
investigating self-perceived physical, emotional and func-
tional disability associated with dizziness. DHI scores
range from 0 to 100. A higher DHI score indicates a
higher level of dizziness-related impairment.43 The DHI
is a widely used self-report questionnaire, designed to
quantify the impact of dizziness on everyday life.
Construct validity exists for the DHI as a reliable indica-
tor of dizziness-related impairment.44 The DHI has high
internal consistency (Cronbach’s α 0.89) and excellent
test–retest reliability (ICC 0.97).43
Subjective improvement in dizziness
The subjective improvement in dizziness symptoms will
be investigated by asking participants to report improve-
ment or no change/worsening in subjective experience
of dizziness (dichotomous) after 3 and 6 months of
follow-up.13
Anxiety and depression
The presence or absence of anxiety and/or depression
—at baseline, and after 3 and 6 months of follow-up—
will be assessed using the PRIME-MD Patient Health
Questionnaire (PHQ),45 an instrument to assess psychi-
atric disorders. This is a self-report questionnaire, which
consists of 59 questions and enquires about recently
experienced psychiatric symptoms. Using the PHQ algo-
rithm, we will determine for each patient the presence
or absence of the diagnoses Panic Disorder, Other
Anxiety Disorder and Major Depressive Disorder at base-
line. The diagnostic algorithms of the PHQ have been
shown to have good criterion validity with reference to
gold standard measures of mental disorders. Patients
might experience these questions about their mental
health as invasive to their privacy. We will assure the
patient that all collected information is strictly conﬁden-
tial and will be anonymised.
Process evaluation outcome measures
Quantitative data
The Problematic Experiences of Therapy Scale
(PETS)46 will be used to compare adherence to treat-
ment in trial arm 1 (stand-alone internet-based VR) and
trial arm 2 (blended care) after 3 and 6 months of
follow-up. Patients in trial arm 3 do not have to ﬁll out
the PETS. The PETS is a brief measure to assess adher-
ence levels and self-reported perceived barriers to adher-
ence to physical rehabilitative therapy. It consists of 12
questions within 5 domains, that is, ‘symptoms too
severe or aggravated by therapy’, ‘uncertainty about how
to carry out the treatment’, ‘doubts about treatment efﬁ-
cacy’, ‘practical problems’ and ‘lack of support’. These
questions are then followed by intervention-speciﬁc
questions about actual adherence levels to elements of
the intervention; the questions to be used in this study
have been used in previous studies of booklet-based
VR.14 20 Engagement of the digital intervention will be
measured by automatically collected detailed data by the
LifeGuide software with regard to intervention usage,
number of logins, page views and time spent on each
page. We will send a survey to all participating GPs and
physiotherapists after the study is concluded to provide
more insights in the views of the healthcare profes-
sionals involved in the intervention. Finally, we will
contact patients who decided to discontinue the trial by
telephone to assess their reason(s) for quitting.
Qualitative data
On their completion of the intervention, we will
perform semistructured face-to-face interviews among a
sample of 20–30 participants, 10–15 participants from
trial arm 1 (stand-alone internet-based VR) and 10–15
participants from trial arm 2 (internet-based VR with
physiotherapeutic support), respectively. The focus of
these interviews is to learn about the patient’s experi-
ences of the VR intervention over the past weeks. The
questions are about participants’ existing management
of their dizziness, their expectations about the VR inter-
vention and initial experiences of engaging with it, any
features they have found especially difﬁcult or especially
helpful, concerns they might have had about continuing
and what they feel they had learnt. All interviews will be
audio-recorded and transcribed verbatim.
Box 1 gives an overview of all measures and times of
collection within the trial.
Statistical analysis
Effectiveness intervention
General characteristics of all participants will be
described quantitatively. The data derived from question-
naires will also be presented in a quantitative way.
Missing data will be handled with multiple imputation
analysis.47 For the effectiveness analysis, we will perform
intention-to-treat and per-protocol analyses. Patients in
trial arms 1 and 2 that have completed all 6 weekly
online sessions will be used for the per-protocol analysis.
We will use multiple linear regression analysis to
compare the primary outcome measure (VSS-SF) in par-
ticipants allocated to trial arm 1 (stand-alone internet-
based VR) and participants allocated to trial arm 2
(internet-based VR with physiotherapeutic support) with
participants allocated to trial arm 3 (usual care). We will
adjust for dizziness severity at baseline (the stratiﬁcation
variable) and any other potential confounders.
Cost-effectiveness intervention
For the cost-effectiveness analysis,48 we will perform cost-
effectiveness and cost–utility analyses with a time horizon
of 6 months, making discounting unnecessary. Societal
costs will be related to the primary outcome of the trial
and QALYs in the economic evaluation. The analysis will
be performed according to the intention-to-treat prin-
ciple. Missing cost and effect data will be imputed using
multiple imputations. Differences in costs and effects will
be estimated using bivariate regression models while
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adjusting for confounders if necessary. Incremental cost-
effectiveness ratios (ICERs) will be calculated by dividing
the difference in mean total costs between the treatment
groups by the difference in mean effects. Bootstrapping
with 5000 replications will be used to estimate 95% CIs
around cost differences and the uncertainty surrounding
the ICERs. Uncertainty surrounding the ICERs will be
graphically presented on cost-effectiveness planes.
Cost-effectiveness acceptability curves showing the prob-
ability that the intervention is cost-effective in compari-
son with usual care for a range of different ceiling ratios
will also be estimated.
Prediction model
We will perform an additional analysis on the data to
identify predictors of successful treatment in patients
with dizziness for all forms of treatment. Secondary
outcome measures will be analysed using linear regres-
sion for continuous outcomes and logistic regression for
dichotomous outcomes, adjusting for dizziness severity
at baseline and any other potential confounders.
According to Moons et al,49 we will develop three predic-
tion models: (1) predictors of successful treatment with
internet-based VR (population: trial arms 1 and 2;
N=200), (2) predictors of successful treatment with
stand-alone internet-based VR (population: trial arm 1;
N=100) and (3) predictors of successful treatment with
internet-based VR with physiotherapeutic support
(population: trial arm 2; N=100). We will perform mul-
tiple logistic regression analysis with ‘successful treat-
ment after six months’ (yes/no) as a dependent
variable. Successful treatment will be deﬁned as: (1)
improvement in the VSS-SF score with at least three
points (clinically signiﬁcant change),8 (2) improvement
in the DHI score with at least 11 points (clinically signiﬁ-
cant change)44 and (3) subjective improvement in dizzi-
ness symptoms.13 Candidate predictors will be easy
obtainable patient characteristics, for example, age,
gender, education and dizziness characteristics. Prior to
regression analysis, we will perform univariate logistic
regression analysis to investigate the associations
between separate candidate predictors and the depend-
ent variable. To assess the reliability of the model, we
will calculate the Hosmer-Lemeshow goodness-of-ﬁt stat-
istic and construct calibration plots. To assess the dis-
criminative ability of the model, we will calculate the
AUC. Since prediction models perform better in devel-
opment cohorts than in other similar populations (over-
ﬁtting), we will perform a bootstrapping procedure.
During this procedure, we will repeat the entire model-
ling process, in order to validate the ﬁnal model and to
adjust (shrink) the estimated performance and regres-
sion coefﬁcients.
Process evaluation analysis
Analysis of quantitative data
The PETS, the LifeGuide software usage data, the survey
results of participating GPs and physiotherapists in the
trial and reasons for discontinuing the trial will all be
analysed using descriptive statistics.
Analysis of qualitative data
Thematic analysis will be employed to identify patterns
within the transcribed face-to-face interviews. Two
researchers will independently read and re-read the ﬁrst
interviews to gain an overall impression and generate a
list of initial codes. This list will be discussed within the
research group, in order to reach consensus on each
code and to categorise the identiﬁed codes into themes.
Once a provisional coding scheme is developed, two
independent researchers will code the other interviews.
Afterwards, the coding results of each interview will be
discussed until consensus is reached. The results of the
qualitative study will be used to provide insights into (1)
patients’ experiences during the intervention and (2)
possible reasons for outcome and adherence results.
DISSEMINATION
An independent monitor from the Clinical Research
Bureau (CRB) of VUmc will have access to the data and
source documents of the trial. Monitoring will be per-
formed in compliance with Good Clinical Practice and
other rules and regulations in order to achieve high-
quality research and secure patient safety.
We aim to widely disseminate the insights and results
of this project to (national and international) GPs, GP
trainees, elderly care physicians, elderly care physician
trainees, physiotherapists and patients with dizziness. We
will publish the research results in international peer-
reviewed journals. There are no restrictions placed on
publication by the sponsor of this study (ZonMw, pro-
gramma Kwaliteit van Zorg: Versnellen, verbreden, vernieu-
wen). If proven effective, we plan to make the
intervention available to all GPs in the Netherlands. The
website of http://www.thuisarts.nl has been developed
by the Dutch College of GPs in 2011 in order to offer
patients reliable medical information and to support
GPs.50 This site is increasingly visited by patients
(6.2 million visitors in ﬁrst half of 2014) and will func-
tion as an important resource to inform patients with
dizziness.50 Finally, we will distribute our results by
means of (national and international) conference pre-
sentations. Up to now, other medical specialties in the
ﬁeld of dizziness, like ENT and neurology, are hardly
aware of the growing expertise on dizziness within the
discipline of general practice. Therefore, we also aim to
disseminate the insights and results of this project to
other relevant medical specialties in the ﬁeld of
dizziness.
DISCUSSION
Introducing blended care to treat dizziness
Research on the effectiveness of the combination of
online and face-to-face therapy (blended care) is scarce
and has never been investigated in patients with vertigo.
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Stand-alone online interventions are susceptible to non-
adherence and attrition. Blended care has been shown
to be able to address these issues.25 For instance, fear of
exacerbation of symptoms may be an important reason
for patients to discontinue their treatment. The encour-
agement and guidance of an experienced physiotherap-
ist at this time may give patients the conﬁdence to keep
doing the exercises.
Providing patients with personalised care
Nowadays, interventions can be tailored to the individual
needs of the patient. Tailored care is created by the
online intervention by continuously re-evaluating the
intensity of the exercises for each patient. Different
patients (with regard to age, gender, education and diz-
ziness characteristics) may also have different prefer-
ences. We will attempt to develop a clinical decision rule
for predictors of successful treatment to ensure persona-
lised treatment. With a decision rule, GPs will be able to
discriminate between patients who are likely to beneﬁt
from stand-alone internet-based VR and those who need
a combination of online and face-to-face therapy
(blended care). The intervention may not only reduce
dizziness and dizziness-related impairment, but also
stimulate patients’ self-management, in line with the
current policy on medical care.
Increasing treatment options for GPs and reducing
healthcare costs
The availability of an effective online intervention will
offer a cost-effective alternative for treating dizziness, as
costly referrals can be avoided. It may stimulate GPs to
reduce inappropriate drug prescribing. According to the
Second Dutch National Survey of General Practice, GPs
prescribed ineffective drugs to as much as 10% of older
patients with dizziness during the ﬁrst consultation.51
Moreover, adverse consequences of dizziness—such as
falls, anxiety and depression—will be reduced, leading
to less healthcare usage and healthcare costs. From a
wider perspective, the project has the capacity to illus-
trate how easily accessible interventions in primary care
may relieve the burden on secondary/tertiary care,
leading to better care at lower costs.52
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